MOA and Clinical Trial Data for Novel and Emerging Therapeutic Strategies for HCM: Can We Target Our Therapy?

Jan 16, 2023 | HCM

1b) Our expert (and returning @cardiomet_ce) author is Giuseppe Galati MD, MMSc in Heart Failure, FHFA, @GiuseppeGalati_ , Consultant #Cardiologist #HeartFailure & #Cardiomyopathies pic.twitter.com/W3CgRK0qAS— cardio-met (@cardiomet_CE) January 17, 2023 3) This...

HCM Prevalence, Pathophysiology, and Natural Course with and without Adequate Medical Treatment

Dec 21, 2022 | HCM

2a) This program is intended for #healthcare providers and is supported by an educational grant from Bristol-Myers Squibb. Statement of accreditation and faculty disclosures at https://t.co/gvXca4GHMU. FOLLOW US for the most timely expert education in #cardiometabolic...